http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021055907-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dcce39a20bef16c3f04497659caba40f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-555
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-282
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184
filingDate 2020-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93975e8f9ed204f544c6f13a9640064f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd75812129dcb6f109c4990cc3840482
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ddc5352fa0bdc81914e94570d7cb413e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_045790f80f56e0b8d31cb1375de4a068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4350fb03d920b1fb62893ad85ee895d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_836d4824395ffdb94792fd517c42bbda
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16d1cc813f681dd452c70dff435411d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d1b8dfa1f2345b9cf04d1f437501db4
publicationDate 2021-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2021055907-A1
titleOfInvention Treatment of cancer
abstract The invention relates to methods for treating a patient diagnosed with ovarian cancer and breast cancer, comprising administering to the patient an effective amount of veliparib in combination with standard-of-care chemotherapy such as carboplatin and paclitaxel.
priorityDate 2019-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015157652-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24337
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396057
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399016
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID12189
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743158
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226443145
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284583
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2064
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423284824
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5352133
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493130
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419498287
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504915
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID672
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135565082
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID505709
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492855
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID386966
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226490700
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID158779662
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419478793
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID353120
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13866
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID497672
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID827854
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449759882
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11960529
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5994
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441341

Total number of triples: 55.